Literature DB >> 19458497

Aptamers and aptamer targeted delivery.

Amy C Yan1, Matthew Levy.   

Abstract

When aptamers first emerged almost two decades ago, most were RNA species that bound and tagged or inhibited simple target ligands. Very soon after, the 'selectionologists' developing aptamer technology quickly realized more potential for the aptamer. In recent years, advances in aptamer techniques have enabled the use of aptamers as small molecule inhibitors, diagnostic tools and even therapeutics. Aptamers are now being employed in novel applications. We review, herein, some of the recent and exciting applications of aptamers in cell-specific recognition and delivery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19458497      PMCID: PMC4821413          DOI: 10.4161/rna.6.3.8808

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  58 in total

1.  Escort aptamers: a delivery service for diagnosis and therapy.

Authors:  B J Hicke; A W Stephens
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

2.  Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer.

Authors:  J Colin Cox; Andrew Hayhurst; Jay Hesselberth; Travis S Bayer; George Georgiou; Andrew D Ellington
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

3.  Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. selective targeting of endothelial regulatory protein pigpen.

Authors:  M Blank; T Weinschenk; M Priemer; H Schluesener
Journal:  J Biol Chem       Date:  2001-02-13       Impact factor: 5.157

Review 4.  Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy.

Authors:  Michael Famulok; Jörg S Hartig; Günter Mayer
Journal:  Chem Rev       Date:  2007-08-23       Impact factor: 60.622

5.  Selection of single-stranded DNA molecules that bind and inhibit human thrombin.

Authors:  L C Bock; L C Griffin; J A Latham; E H Vermaas; J J Toole
Journal:  Nature       Date:  1992-02-06       Impact factor: 49.962

6.  Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting.

Authors:  Marie-Sophie L Raddatz; Andreas Dolf; Elmar Endl; Percy Knolle; Michael Famulok; Günter Mayer
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

7.  Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.

Authors:  James O McNamara; Eran R Andrechek; Yong Wang; Kristi D Viles; Rachel E Rempel; Eli Gilboa; Bruce A Sullenger; Paloma H Giangrande
Journal:  Nat Biotechnol       Date:  2006-06-25       Impact factor: 54.908

8.  Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples.

Authors:  Dihua Shangguan; Zehui Charles Cao; Ying Li; Weihong Tan
Journal:  Clin Chem       Date:  2007-04-26       Impact factor: 8.327

9.  Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy.

Authors:  Jiehua Zhou; Haitang Li; Shirley Li; John Zaia; John J Rossi
Journal:  Mol Ther       Date:  2008-05-06       Impact factor: 11.454

10.  Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.

Authors:  Yu-Fen Huang; Dihua Shangguan; Haipeng Liu; Joseph A Phillips; Xiaoling Zhang; Yan Chen; Weihong Tan
Journal:  Chembiochem       Date:  2009-03-23       Impact factor: 3.164

View more
  20 in total

Review 1.  Cell-specific aptamer-mediated targeted drug delivery.

Authors:  Jiehua Zhou; John J Rossi
Journal:  Oligonucleotides       Date:  2010-12-23

Review 2.  Optimizing siRNA delivery to the genital mucosa.

Authors:  Joseph A Katakowski; Deborah Palliser
Journal:  Discov Med       Date:  2011-02       Impact factor: 2.970

3.  Orchestrating a Symphony on a Single Conjugate: Aptamer Targeting, Gene Silencing, and Immunomodulation to Enhance Antitumor Response.

Authors:  Brandon D Ng; Dan Peer
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

Review 4.  Promising new assays and technologies for the diagnosis and management of infectious diseases.

Authors:  S F Mitsuma; M K Mansour; J P Dekker; J Kim; M Z Rahman; A Tweed-Kent; P Schuetz
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

5.  RNA aptamers and their therapeutic and diagnostic applications.

Authors:  Katherine Germer; Marissa Leonard; Xiaoting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2013-03-31

6.  Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.

Authors:  Robert M Sharkey; Edmund A Rossi; Chien-Hsing Chang; David M Goldenberg
Journal:  Cancer Biother Radiopharm       Date:  2010-02       Impact factor: 3.099

Review 7.  siRNA-based topical microbicides targeting sexually transmitted infections.

Authors:  Joseph A Katakowski; Deborah Palliser
Journal:  Curr Opin Mol Ther       Date:  2010-04

Review 8.  The emerging role of epigenetics in stroke: II. RNA regulatory circuitry.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Arch Neurol       Date:  2010-12

9.  Aptamer-targeted cell-specific RNA interference.

Authors:  Jiehua Zhou; John J Rossi
Journal:  Silence       Date:  2010-02-01

Review 10.  Receptor-targeted nanocarriers for therapeutic delivery to cancer.

Authors:  Bo Yu; Heng Chiat Tai; Weiming Xue; L James Lee; Robert J Lee
Journal:  Mol Membr Biol       Date:  2010-10       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.